The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Titov K.S.

S.P. Botkin City Clinical Hospital Department of Healthcare of Moscow

Karpenko R.V.

S.P. Botkin City Clinical Hospital Department of Healthcare of Moscow

Lebedev S.S.

S.P. Botkin City Clinical Hospital

Grekov D.N.

S.P. Botkin City Clinical Hospital

Yakusheva T.A.

S.P. Botkin City Clinical Hospital

Multiple primary synchronous tumors: features of modern diagnosis and treatment

Authors:

Titov K.S., Karpenko R.V., Lebedev S.S., Grekov D.N., Yakusheva T.A.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2024;13(1): 63‑69

DOI: 10.17116/onkolog20241301163

Read: 2663 times

Download PDF (RU)
Contact the author
Table of contents

MULTIPLE PRIMARY SYNCHRONOUS TUMORS: FEATURES OF MODERN DIAGNOSIS AND TREATMENT
MULTIPLE PRIMARY SYNCHRONOUS TUMORS: FEATURES OF MODERN DIAGNOSIS AND TREATMENT

To cite this article:

Titov KS, Karpenko RV, Lebedev SS, Grekov DN, Yakusheva TA. Multiple primary synchronous tumors: features of modern diagnosis and treatment. P.A. Herzen Journal of Oncology. 2024;13(1):63‑69. (In Russ.)
https://doi.org/10.17116/onkolog20241301163

Подписка 2026 Онкология. Журнал им. П.А. Герцена (P.A. Herzen Journal of Oncology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

In recent decades, there has been an increase in the number of multiple primary malignant tumors. In the Russian Federation in 2021.10% of all newly diagnosed cases accounted for multiple primary tumors (58.217 cases). This is 2.12 times higher than for the same period in 2011 when 24.774 cases were recorded, constituting 4.7% of the total. Treatment of metachronous tumors often involves sequential treatment of each individual neoplasm and does not usually raise significant debates. Conversely, the treatment of synchronous tumors can be challenging. Despite advancements in cancer therapies, the issue of choosing a treatment strategy for synchronous tumors remains unresolved. There are still no unified clinical recommendations for treating this group of patients. Large randomized studies demonstrating the superiority of specific treatment methods and strategies are lacking in contemporary literature. This review analyzes the literature data on the methods used and the treatment outcomes in this group of patients.

Keywords:

multiple primary synchronous tumors
etiological factors of multiple primary malignancies
treatment of multiple primary synchronous tumors

Authors:

Titov K.S.

S.P. Botkin City Clinical Hospital Department of Healthcare of Moscow

Karpenko R.V.

S.P. Botkin City Clinical Hospital Department of Healthcare of Moscow

Lebedev S.S.

S.P. Botkin City Clinical Hospital

Grekov D.N.

S.P. Botkin City Clinical Hospital

Yakusheva T.A.

S.P. Botkin City Clinical Hospital

Received:

17.06.2023

Accepted:

26.07.2023

Close metadata

References:

  1. Kaprin AD, Starinskii VV, Shakhzadova AO, eds. Sostoyanie onkologicheskoi pomoshchi naseleniyu Rossii v 2021 godu. M.: MNIOI im. P.A. Gertsena — filial FGBU «NMITs radiologii» Ministerstva zdravookhraneniya Rossiiskoi Federatsii; 2022;239. (In Russ.).
  2. Chissov VI, Starinskii VV, Petrova GV, eds. Sostoyanie onkologicheskoi pomoshchi naseleniyu Rossii v 2011 godu. M.: FGBU «MNIOI im. P.A. Gertsena» Minzdravsotsrazvitiya Rossiiskoi Federatsii; 2012;240. (In Russ.).
  3. Stepanova YuA, Kalinin DV, Vishnevskii VA. Primary multiple tumors (literature review). Meditsinskaya Vizualizatsiya. 2015;(6):93-102. (In Russ.).
  4. Jensen OM, Storm HH, Jensen HS. Cancer registration in Denmark and the study of multiple primary cancers, 1943—80. Natl Cancer Inst Monogr. 1985;68:245-251. 
  5. Coleman MP. Multiple primary malignant neoplasms in England and Wales, 1971—1981. Yale J Biol Med. 1986;59(5):517-531. 
  6. Vogt A, Schmid S, Heinimann K, Frick H, Herrmann C, Cerny T, Omlin A. Multiple primary tumours: challenges and approaches, a review. ESMO Open. 2017;2(2):e000172. https://doi.org/10.1136/esmoopen-2017-000172
  7. Warren S. Multiple primary malignant tumors. A survey of the literature and a statistical study. Am J Cancer. 1932;16:1358-1414.
  8. Chissov VI, Davydov MI, eds. Onkologiya. Natsional’noe rukovodstvo. M.: GEOTAR-media; 2008;1072. (In Russ.).
  9. Minagawa Y. Trends in happy life expectancy in Russia, 1994—2015. SSM Popul Health. 2021;17:101005. https://doi.org/10.1016/j.ssmph.2021.101005
  10. IARC Monographs on the Evaluation of Carcinogenic Risk to Humans. Personal habits and indoor combustions. Vol. 100e. A review of human carcinogens. Lyon, France: IARC Press; 2012;599. 
  11. Zaridze DG, Mukeriya AF. The effect of smoking on the prognosis of the disease in cancer patients. Voprosy Onkologii. 2019;65(3):321-329. (In Russ.).
  12. Klyaritskaya IL, Is’kova IA. The role of alcohol in the development of gastrointestinal cancer. Krymskii Terapevticheskii Zhurnal. 2007;2(2):18-23. (In Russ.).
  13. Dvoryaninova OYu, Choinzonov EL, Litvyakov NV. Clinical aspects of HPV-positive cancer of the oral cavity and oropharynx. Vestnik Oto-Rino-Laringologii. 2016;81(1):72-77. (In. Russ.). https://doi.org/10.17116/otorino201681172-77
  14. Parkin DM, Bray F. Chapter 2: the burden of HPV-related cancers. Vaccine. 2006;24(suppl 3):S3/11-25.  https://doi.org/10.1016/j.vaccine.2006.05.111
  15. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118(12):3030-3044. https://doi.org/10.1002/ijc.21731
  16. Golmard L, Delnatte C, Laugé A, Moncoutier V, Lefol C, Abidallah K, Tenreiro H, Copigny F, Giraudeau M, Guy C, et al. Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations. Oncogene. 2016;35(10):1324-1327. https://doi.org/10.1038/onc.2015.181
  17. Stroganova AM, Pospekhova NI, Golovina DA, Cherepanova IS, Dranko SL, Filippova MG. Analysis of the results of long-term mass screening of mutations in the BRCA1/2 genes in patients with various types of malignant neoplasms. Russkii Meditsinskii Zhurnal. Meditsinskoe Obozrenie. 2022;6(6):297-308. (In Russ.). https://doi.org/10.32364/2587-6821-2022-6-6-297-308
  18. Pan Z, Xie X. BRCA mutations in the manifestation and treatment of ovarian cancer. Oncotarget. 2017;8(57):97657-97670. https://doi.org/10.18632/oncotarget.18280
  19. Godet I, Gilkes DM. BRCA1 and BRCA2 mutations and treatment strategies for breast cancer. Integr Cancer Sci Ther. 2017;4(1):10.15761/ICST.1000228. https://doi.org/10.15761/ICST.1000228
  20. Lynch HT, Snyder CL, Shaw TG, Heinen CD, Hitchins MP. Milestones of Lynch syndrome: 1895—2015. Nat Rev Cancer. 2015;15(3):181-194.  https://doi.org/10.1038/nrc3878
  21. Giardiello FM, Allen JI, Axilband JE, Boland CR, Burke CA, Burt RW, Church JM, Dominitz JA, Johnson DA, Kaltenbach T, et al. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Dis Colon Rectum. 2014;57(8):1025-1048. https://doi.org/10.1097/DCR.000000000000000
  22. Moreira L, Balaguer F, Lindor N, de la Chapelle A, Hampel H, Aaltonen LA, Hopper JL, Le Marchand L, Gallinger S, Newcomb PA, et al.; EPICOLON Consortium. Identification of Lynch syndrome among patients with colorectal cancer. JAMA. 2012;308(15):1555-1565. https://doi.org/10.1001/jama.2012.13088
  23. Hampel H, Frankel W, Panescu J, Lockman J, Sotamaa K, Fix D, Comeras I, La Jeunesse J, Nakagawa H, Westman JA, et al. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res. 2006;66(15):7810-7817. https://doi.org/10.1158/0008-5472.CAN-06-1114
  24. Kratz CP, Freycon C, Maxwell KN, Nichols KE, Schiffman JD, Evans DG, Achatz MI, Savage SA, Weitzel JN, Garber JE, et al. Analysis of the Li-Fraumeni spectrum based on an International Germline TP53 Variant Data Set: an International Agency for Research on Cancer TP53 Database Analysis. JAMA Oncol. 2021;7(12):1800-1805. https://doi.org/10.1001/jamaoncol.2021.4398
  25. Chittiboina P, Lonser RR. Von Hippel-Lindau disease. Handb Clin Neurol. 2015;132:139-156.  https://doi.org/10.1016/B978-0-444-62702-5.00010-X
  26. Goncharenko GV. Pervichno-mnozhestvennye zlokachestvennye opukholi naibolee rasprostranennykh lokalizatsii — statistika onkologicheskogo kabineta polikliniki. Research’n Practical Medicine Journal. 2015;2(4):59-65. (In Russ.). https://doi.org/10.17709/2409-2231-2015-2-4-59-65
  27. Yang XB, Zhang LH, Xue JN, Wang YC, Yang X, Zhang N, Liu D, Wang YY, Xun ZY, Li YR, et al. High incidence combination of multiple primary malignant tumors of the digestive system. World J Gastroenterol. 2022;28(41):5982-5992. https://doi.org/10.3748/wjg.v28.i41.5982
  28. Zhai C, Cai Y, Lou F, Liu Z, Xie J, Zhou X, Wang Z, Fang Y, Pan H, Han W. Multiple primary malignant tumors — a clinical analysis of 15,321 patients with malignancies at a single center in China. J Cancer. 2018;9(16):2795-2801. https://doi.org/10.7150/jca.25482
  29. Jiao F, Yao LJ, Zhou J, Hu H, Wang LW. Clinical features of multiple primary malignancies: a retrospective analysis of 72 Chinese patients. Asian Pac J Cancer Prev. 2014;15(1):331-334.  https://doi.org/10.7314/apjcp.2014.15.1.331
  30. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424.  https://doi.org/10.3322/caac.21492
  31. Trentham-Dietz A, Newcomb PA, Nichols HB, Hampton JM. Breast cancer risk factors and second primary malignancies among women with breast cancer. Breast Cancer Res Treat. 2007;105(2):195-207.  https://doi.org/10.1007/s10549-006-9446-y
  32. Qiu M, Lian YY, Lu M, Wang BS, Tian XJ, Lu J, Liu C, Zhang SD, Jiang M, Ma LL. [Treatment and prognosis of multiple primary malignant neoplasms complicated with renal cell carcinoma]. Beijing Da Xue Xue Bao Yi Xue Ban. 2022;54(4):680-685. (In Chinese). https://doi.org/10.19723/j.issn.1671-167X.2022.04.016
  33. Skoropad VYu, Berdov BA. Results of treatment of primary multiple malignant tumors with localization of one of them in the stomach. Voprosy Onkologii. 2007;(3):298-303. (In Russ.).
  34. Leonov OV, Dolgikh VT, Kopyl’tsov EI, Alekseev BYa. Primary multiple malignant neoplasms with lesions of the genitourinary organs. Onkourologiya. 2010;(2):56-60. (In Russ.).
  35. Zeng QA, Qiu J, Zou R, Li Y, Li S, Li B, Huang P, Hong J, Zheng Y, Lao X, et al. Clinical features and outcome of multiple primary malignancies involving hepatocellular carcinoma: a long-term follow-up study. BMC Cancer. 2012;12:148.  https://doi.org/10.1186/1471-2407-12-148
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.